ML20073C876

From kanterella
Jump to navigation Jump to search
Proposed Tech Specs Change Request 104,Rev 1 Re Surveillance Capsule Insertion & Withdrawal
ML20073C876
Person / Time
Site: Crane Constellation icon.png
Issue date: 04/05/1983
From:
GENERAL PUBLIC UTILITIES CORP.
To:
Shared Package
ML20073C858 List:
References
NUDOCS 8304130331
Download: ML20073C876 (6)


Text

.

1.

TECHNICAL SPECIFICATION CHANGE REQUEST NO. 104, REV. 1 The' Licensee requests the attached changed pages replace the following pages of the existing Technical Specification:

Appendix A Replace 4-12, 4-13 and 4-27a II.

REASON FOR CHANGE REQUEST As part of the Integrated RV Material Surveillance Program (RVMSP) of the B6W Owners Group (B&W OG), TMI-l Capsule TMI-lC, which is presently being irradiated at CR-3, is proposed to be withdrawn, tested and evaluated in accordance with a recommended new withdrawal schedule.

Implementation of this new schedule will require a change to the Technical Specification for TMI-1, particularly Table.4.2-2.

III.

SAFETY EVALUATION JUSTIFYING CHANGE The following reasons provide the technical basis for the change:

1 1.

The implementation of low leakage fuel cycles at most B6W designed plants, including ihree Mile Island Unit 1, caused a corresponding decrease in the estimated end-of-life (EOL) fluences for affected reactor vessels.

If capsule withdrawal continues according to the current schedule, a major portion of the capsule currently undergoing irradiation will accumulate fluences well in excess of estimated vessel EOL.

Consequently, the data obtained from evaluation of these capsules will not be useful for evaluation of corresponding vessel integrity. The attached table 1 for TMI-l illustrates the impact of this fuel cycle design change. The revised schedule will assure acquisition of representative capsule data which can be related to the irradiated construction of the vessel.

2.

The withdrawal schedule, as specified in ASTM Spec. E-185-79 referenced in 10 CFR 50, Appendix H, requires that capsules _be withdrawn at designated intervals such that the capsule fluence will correspond to specified conditions of the reactor vessel.

with respect to irradiation damage. Although the B&W OG Integrated RVMSP was designed prior to E-185-79, regulations require that the program be maintained, to the extent practical, with the updated requirements. Therefore, to insure that capsules are withdrawn in a manner consistent with the required compatibility of capsule fluence and RV fluence, it is necessary to revise the current withdrawal sequence.

The attached Table 4.2-2 shows the proposed change.

This table,which is part of the TMI-l Tech Spec,should cover the recommended new withdrawal schedule of the 36W OG.

Mr. Warren Hazleton of the NRC staff has been consulted on this change and is aware of the new B&W OG withdrawal schedule.

Additionally, Sections 4.2.5 and 4.2.6 have been deleted.

Section 4.2.5 currently requires submission of a special report or an application for a License Amendment should Crystal River - Unit 3 cummulative reactor utilization factor (CRUF) 0304130331 830405 PDR ADOCK 05000289 p

PDR

.i

.~

l l

i drop.below 65%. The' original TSCR No. 104 requested to change therethod inwhich CRUF was to be calculated. The integrater; RVMSP is continuously being updated to reflect actual fluence accumulations in the operating host reactors.

Since the BIN OG Integrated Reactor Vessel Material Surveillance Program has been revised,.there is no longer a need for either a special report or an application for a license amendment based on Crystal River - Unit 3 CRUF.

l The special report requested in 4.2.6 was submitted Septe=ber 17, 1982-l (5211-82-225) so this requirement has been fulfilled and need not remain in the TMI-1 Technical Specifications.

In summary, the proposed change in TMI-1 surveillance' capsule insertion and withdrawal schedule not only refines our methodology to satisfy the requirements of 10 CFR 50, Appendix G and H, but also results in a more l

realistic evaluation of vessel integrity.

IV.

AMENDMENT CLASSIFICATION (10 CFR 170.22) t' Check No. 034612 was provided with Technical Specification Change Request No. 104, Rev. O dated June 8,1981.

1 V.

1MPLEMENTION PERIOD i

i It is requested that this amendment be made effective i= mediately upon issuance.

1

'\\

{

)

i i

t 1

i i

i

--.-._,l_._..-.,._,..

T/ ALE 1

SUMMARY

OF TMI-IC RVSP CAPSULE FLUENCE ACCUMULATION 0 EXPECTED CAPSULE ACCUMULATED FLUENCE

5. 8 x 1018 n/cm2 IF TMI-1C REMOVED AFTER CR-3 4TH CYCLE AS RECOMMENDED IN 3/83 o EXPECTED CAPSULE ACCUMULATED FLUENCE
8. 5 x 1018 IF TMI-1C REMOVED AFTER CR-3 STH CYCLE ANTICIPATED IN 9/84 o ESTIMATED PEAK TMI-I VESSEL FLUENCE 1.8 x 1018 ACCUMULATION AS OF 12/31/82 l

3 o ESTIMATED PEAK TMI-1 VESSEL FLUENCE 1.3 x 1019 ACCUMULATION AT 32EFPY (ASSUMING LOW LEAKAGE CORE) o ESTIMATED 1/4T TMI-1, VESSEL FLUENCE 7.2 x 1018 ACCUMULATION AT 32EFPY (ASSUMING LOW LEAKAGE CORE)

CONCLUSION:

WITHDRAW TMI-1C AT EARLIEST POSSIBLE DATE (3/83) TO OBTAIN A FLUENCE CONSISTENT WITH THE INTENT OF 10CFR50 APPENDIX H AND O WF-25 WELD METAL.

w~

r I

I l

l l

l 4.2.5 1

THIS SECTION LEFT INTENTIONALLY BLANK l

4.2.6 THIS SECTION LEFT INTENTIONALLY BLANK 4.2.7 A surveillance program for the pressure isolation valves between the primary coolant system and the low pressure injection system shall be as follows:

Periodic leakage testing (a) at test differential pressure greater 1.

than 150 psid shall be accomplished for the valves listed in Table 3.1.6.1 for the following conditions:

(a) prior to achieving hot shutdown after returning the valve to service following maintenance repair or replacement work, and (b) prior to achieving hot shutdown following a cold shutdown of greater than 72 hours8.333333e-4 days <br />0.02 hours <br />1.190476e-4 weeks <br />2.7396e-5 months <br /> duration unless testing has been per-formed within the previous 9 ucnths.

2.

Whenever integrity of a pressure isolation valve listed in Table 3.1.6.1 cannot be demonstrated, the integrity of the other remaining valve in,each high pressure line having a leaking valve shall be determined and recorded daily.

In addition, the position of one other valve located in the high pressure piping shall be recorded daily.

i I

(a) To satisfy ALARA requirements, leakage may be measured indirectly (as from l

the performance of pressure indicators) if accomplished in accordance with approved procedures and supported by computations showing that the method-is capable of demonstrating valve compliance with leakage criteria.

4-12

i b.

Because of damage to the surveillance capsule holder tubes originally installed in TMI-1, irradiation of the TMI-1 capsules was to be conducted in TMI-2 pursuant to 10 CFR 50, Appendix H, Section II.C.4.

One of the five remaining TMI-l capsules (Capsule E had been withdrawn and tested

{

earlier) was installed in a holder tube in the THI-2 reactor at the initial startup of TMI-2.

The other four capsules were scheduled for later insertions.

However, due to the TMI-2 Incident, Unit 2 may be out of operation for a considerably longer period of time than will be TMI-1.

So that TMI-1 will have an ongoing surveillance program, a TMI-1 capsule will be inserted into a holder tube in the Crystal River Unit 3 (CR-3) reactor.

Because similarities exist between TMI-l and CR-3, appropriate adjustments and margins can be imposed to the surveillance capsule irradiation in CR-3 to account for such differences that may exist in the irradiation exposure of the TMI-l reactor vessel and the surveillance capsule.

4 The withdrawal schedule has been formulated to optimize the availability of irradiation data from all the capsules being irradiated in the CR-3 reactor.

t 1

4-13

TABLE 4.2-2 A.

SURVEILLANCE CAPSULE INSERTION & WITHDRAWAL SCHEDULE AT DiI-2 (Note: This schedule will be revised at a later date pending the restart schedules of DiI-1 and DfI-2. )

Capsule Designation Insertion Withdrawal DfI-1A DfI-2 Start-up End of 3rd Cycle DiI-1B End of 1st '.ycle End of 6th Cycle TMI-1D End of 6th Cycle End of 15th Cycle Dil-1E Removed end of 1st t

Cycle of TMI-1 TMI-1F End of 10th Cy'cle End of 24th Cycle B.

SURVEILLANCE CAPSULE INSERTION & WITHDRAWAL SCHEDULE AT CR-3 i

Capsule Designation Insertion Withdrawal j

l Dil-1C End of 2nd Cycle End of 4th Cycle Dil-1B End of 4th Cycle End of 6th Cycle

)

TM1-1D End of 6th Cycle End of lith Cycle Dil-1F End of 7th Cycle End of 12th Cycle l

l 4-27a

. _ _ _ _ - _ _ - - _ _ _ - _ _ _ _ - _ _ _ - - _ _ _ _ _ _ _ -.